Matthew A. Croxen

5.1k total citations · 2 hit papers
57 papers, 3.6k citations indexed

About

Matthew A. Croxen is a scholar working on Infectious Diseases, Endocrinology and Epidemiology. According to data from OpenAlex, Matthew A. Croxen has authored 57 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 19 papers in Endocrinology and 17 papers in Epidemiology. Recurrent topics in Matthew A. Croxen's work include Escherichia coli research studies (16 papers), Vibrio bacteria research studies (10 papers) and Salmonella and Campylobacter epidemiology (9 papers). Matthew A. Croxen is often cited by papers focused on Escherichia coli research studies (16 papers), Vibrio bacteria research studies (10 papers) and Salmonella and Campylobacter epidemiology (9 papers). Matthew A. Croxen collaborates with scholars based in Canada, United States and United Kingdom. Matthew A. Croxen's co-authors include B. Brett Finlay, Roland W. Scholz, Marta Wlodarska, Kristie M. Keeney, Paul S. Hoffman, Gary Sisson, Benjamin P. Willing, Nunilo Cremades, Roberto G. Melano and Rosana B. R. Ferreira and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Matthew A. Croxen

54 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent Advances in Understanding Enteric Pathogenic Escherichia coli

2013 1.1k citations Matthew A. Croxen, Roland W. Scholz et al. profile →
Molecular mechanisms of Escherichia coli pathogenicity

2009 841 citations Matthew A. Croxen, B. Brett Finlay profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew A. Croxen Canada	23	1.6k	1.3k	1.0k	828	521	57	3.6k
Tadasuke Ooka Japan	30	1.7k 1.1×	1.1k 0.9×	1.4k 1.3×	692 0.8×	356 0.7×	66	3.8k
Alexander W. Friedrich Netherlands	31	1.4k 0.9×	1.3k 1.0×	924 0.9×	443 0.5×	611 1.2×	76	3.1k
Koné Kaniga United States	30	1.1k 0.7×	1.3k 1.0×	1.0k 1.0×	889 1.1×	873 1.7×	46	4.2k
Kumar Rajakumar United Kingdom	32	1.0k 0.6×	955 0.7×	1.4k 1.3×	384 0.5×	894 1.7×	75	3.4k
Tobias A. Oelschlaeger Germany	33	933 0.6×	541 0.4×	1.6k 1.5×	1.1k 1.4×	354 0.7×	61	3.6k
Junkal Garmendia Spain	33	1.3k 0.8×	741 0.6×	1.0k 1.0×	469 0.6×	704 1.4×	79	3.4k
Sören Schubert Germany	41	1.7k 1.1×	865 0.7×	1.5k 1.4×	638 0.8×	1.2k 2.3×	114	5.2k
Toru Tobe Japan	21	1.3k 0.8×	1.0k 0.8×	1.9k 1.8×	965 1.2×	217 0.4×	38	3.7k
Satheesh Nair United Kingdom	35	1.5k 0.9×	830 0.6×	1.1k 1.0×	2.5k 3.0×	1.2k 2.3×	89	4.5k
Minh‐Duy Phan Australia	36	1.4k 0.9×	611 0.5×	1.3k 1.3×	547 0.7×	1.5k 2.9×	97	3.9k

Countries citing papers authored by Matthew A. Croxen

Since Specialization

Citations

This map shows the geographic impact of Matthew A. Croxen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Croxen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Croxen more than expected).

Fields of papers citing papers by Matthew A. Croxen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Croxen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Croxen. The network helps show where Matthew A. Croxen may publish in the future.

Co-authorship network of co-authors of Matthew A. Croxen

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Croxen. A scholar is included among the top collaborators of Matthew A. Croxen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Croxen. Matthew A. Croxen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, J. S. W., Matthew A. Croxen, Aducio Thiesen, et al.. (2025). The assembly of a hybrid type IV secretion system by a Crohn’s disease-associated Escherichia coli strain. Nature Communications. 16(1). 8797–8797.

Tyrrell, Gregory J., et al.. (2024). Group A streptococcal infections in Alberta, Canada 2018–2023. Epidemiology and Infection. 153. e35–e35. 3 indexed citations

Mataseje, Laura, Johann Pitout, Matthew A. Croxen, M. R. Mulvey, & Tanis C. Dingle. (2023). Three separate acquisitions of blaNDM-1 in three different bacterial species from a single patient. European Journal of Clinical Microbiology & Infectious Diseases. 42(10). 1275–1280. 2 indexed citations

Zelyas, Nathan, Kanti Pabbaraju, Matthew A. Croxen, et al.. (2023). Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing. Scientific Reports. 13(1). 17478–17478.

Croxen, Matthew A., et al.. (2023). Genomic characterization of emerging invasive Streptococcus agalactiae serotype VIII in Alberta, Canada. European Journal of Clinical Microbiology & Infectious Diseases. 42(6). 747–757. 5 indexed citations

Pabbaraju, Kanti, Nathan Zelyas, Anita Wong, et al.. (2022). Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern. Journal of Virological Methods. 307. 114553–114553. 9 indexed citations

Nadon, Céline, et al.. (2022). Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratories. BMC Public Health. 22(1). 1817–1817. 3 indexed citations

Asadi, Leyla, Matthew A. Croxen, Courtney Heffernan, et al.. (2022). How much do smear-negative patients really contribute to tuberculosis transmissions? Re-examining an old question with new tools. EClinicalMedicine. 43. 101250–101250. 22 indexed citations

Law, John Lok Man, Michael Logan, Michael Joyce, et al.. (2021). SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1. Vaccine. 39(40). 5769–5779. 24 indexed citations

10.

Dingle, Tanis C., et al.. (2021). Histoplasmosis acquired in Alberta, Canada: an epidemiological and genomic study. The Lancet Microbe. 2(5). e191–e197. 13 indexed citations

11.

Croxen, Matthew A., et al.. (2021). Phenotypic changes in group B streptococci grown in the presence of the polyols, erythritol, sorbitol and mannitol. BMC Microbiology. 21(1). 145–145. 3 indexed citations

12.

Kanji, Jamil N., Kanti Pabbaraju, Matthew A. Croxen, et al.. (2021). Characterization of Swine Influenza A(H1N2) Variant, Alberta, Canada, 2020. Emerging infectious diseases. 27(12). 3045–3051. 3 indexed citations

13.

Pandey, Manisha, Victoria Ozberk, Zhenjun Chen, et al.. (2019). Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice. Science Advances. 5(9). eaax3013–eaax3013. 11 indexed citations

14.

Skowronski, Danuta M., Suzana Sabaiduc, Michelle Murti, et al.. (2019). Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019. Eurosurveillance. 24(4). 43 indexed citations

15.

Uyaguari, Miguel, Michael W.Y. Chan, Bonnie Chaban, et al.. (2016). A comprehensive method for amplicon-based and metagenomic characterization of viruses, bacteria, and eukaryotes in freshwater samples. Microbiome. 4(1). 20–20. 62 indexed citations

16.

Yu, Hong, Matthew A. Croxen, Amanda M. Marchiando, et al.. (2014). Autophagy Facilitates Salmonella Replication in HeLa Cells. mBio. 5(2). e00865–14. 71 indexed citations

17.

Sal‐Man, Neta, Esther Biemans‐Oldehinkel, David Sharon, et al.. (2012). EscA Is a Crucial Component of the Type III Secretion System of Enteropathogenic Escherichia coli. Journal of Bacteriology. 194(11). 2819–2828. 5 indexed citations

18.

Shames, Stephanie R., Amit P. Bhavsar, Matthew A. Croxen, et al.. (2011). The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300. Cellular Microbiology. 13(10). 1542–1557. 46 indexed citations

19.

Deng, Wanyin, Carmen L. de Hoog, Hong Yu, et al.. (2009). A Comprehensive Proteomic Analysis of the Type III Secretome of Citrobacter rodentium. Journal of Biological Chemistry. 285(9). 6790–6800. 60 indexed citations

20.

Hoffman, Paul S., Gary Sisson, Matthew A. Croxen, et al.. (2006). Antiparasitic Drug Nitazoxanide Inhibits the Pyruvate Oxidoreductases of Helicobacter pylori , Selected Anaerobic Bacteria and Parasites, and Campylobacter jejuni. Antimicrobial Agents and Chemotherapy. 51(3). 868–876. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact